Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment

导出原文传递

翻译打印收藏纠错

作者： Hengli,Zhao ^[1] ; Zhirui,Zhao ^[2] ; Kun,He ^[3] ; Nianrong,Mi ^[4] ; Kai,Lou ; Xiaolin,Dong ; Wenyu,Zhang ; Jingfang,Sun ; Xinyu,Hu ; Shuguang,Pang ; Hong,Cheng ; Qing,Wen

作者单位： Department of Clinical Research Center,Central Hospital Affiliated to Shandong First Medical ^[1] Department of Renal Division,Beijing Anzhen Hospital, Capital Medical University ^[2] Department of Endocrinology,Central Hospital Affiliated to Shandong First Medical University ^[3] Jilin Huisheng Biopharmaceutical Co., Ltd. ^[4]

发布时间 2023-09-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical pharmacokinetics

2023年62卷8期

1093-1103页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment

Clinical pharmacokinetics

相似文献

Clinical pharmacokinetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment

Clinical pharmacokinetics

相似文献

Clinical pharmacokinetics

相关期刊

检索历史清除